Entity coverage

Regeneron Pharmaceuticals, Inc.

REGN · 5 events mapped

Market Ontology has mapped 5 distinct macro, policy, and market events to REGN. Each entry below traces the causal channel from the driver to the assumption it moved.

Recent event impacts

Full ledger →
  • 2026-07-17EventIncreased competitive pressure in the nephrology/rare kidney disease market, potential for reduced market share for future IgAN treatments.
  • 2026-07-17EventPotential competitive pressure in the immunology and rare disease space, influencing R&D priorities and market dynamics.
  • 2026-06-23EventIncreased competitive threat to Dupixent (co-marketed with Sanofi), a leading treatment for atopic dermatitis and asthma. AbbVie's new assets could challenge Dupixent's market dominance in the long term.
  • 2026-06-16EventPotential new competitor in the wet AMD market, impacting market share and pricing power for existing treatments.
  • 2026-06-12EventPotential future competition in the cardiovascular/lipid-lowering market, though current impact is indirect.

Continuous coverage for REGN with alerts, structural playbooks, and options routing lives in the platform. Start a trial →